• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Sushi, cervice and gnathostomiasis - A case report and review of imported infections
We describe a case of imported cutaneous gnathostomiasis in a Thai patient living in France. Gnathostomiasis is a zoonosis of food origin. The disease is endemic in Southeast Asia and Latin America. However, over the past 30 years, an increasing number of imported cases has been described in Europe and America. The disease is rare in Western Europe and the majority of cases described had a cutaneous clinical presentation. The disease may sometimes be confused with allergy, leading to a delay in diagnosis.
Source: Travel Medicine and Infectious Disease - October 16, 2017 Category: Infectious Diseases Authors: Jordan Leroy, Marjorie Cornu, Anne Sophie Deleplancque, S éverine Loridant, Emmanuel Dutoit, Boualem Sendid Source Type: research

Sushi, ceviche and gnathostomiasis - A case report and review of imported infections
We describe a case of imported cutaneous gnathostomiasis in a Thai patient living in France. Gnathostomiasis is a zoonosis of food origin. The disease is endemic in Southeast Asia and Latin America. However, over the past 30 years, an increasing number of imported cases has been described in Europe and America. The disease is rare in Western Europe and the majority of cases described had a cutaneous clinical presentation. The disease may sometimes be confused with allergy, leading to a delay in diagnosis.
Source: Travel Medicine and Infectious Disease - October 16, 2017 Category: Infectious Diseases Authors: Jordan Leroy, Marjorie Cornu, Anne Sophie Deleplancque, S éverine Loridant, Emmanuel Dutoit, Boualem Sendid Source Type: research

Dengue vaccines: Are they safe for travelers?
The four dengue viruses (DENV) circulate among nearly one-half of the world's population in tropical and semitropical countries imposing a huge morbidity burden on travelers. Sanofipasteur has developed a tetravalent live-attenuated vaccine, Dengvaxia, recently approved by the World Health Organization and licensed in four dengue-endemic countries. An additional two dengue vaccines, developed by the National Institute of Allergy and Infectious Diseases (NIAID), USA and Takeda, are entering phase III testing.
Source: Travel Medicine and Infectious Disease - June 21, 2016 Category: Infectious Diseases Authors: Scott B. Halstead, Maira Aguiar Tags: Commentary Source Type: research